Life Sciences Times, Author at Boston Life Sciences Times

Konovo Appoints Jessica Santos as Chief Compliance and Privacy Officer

March 3, 2026

Takeda, Protagonist Secure FDA Priority Review for Rusfertide in Polycythemia Vera

March 2, 2026

Boston Reclaims Top Spot in U.S. Life Sciences Leasing as Market Stabilizes

February 27, 2026

THIS WEEK'S STORIES

Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases

March 3, 2026

KalVista Highlights Patient Satisfaction, Early Treatment Benefits for EKTERLY at Major Allergy Meetings

March 2, 2026

Enveric Biosciences Says Patent Challenge Has Been Withdrawn

February 25, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication

Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team

Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases

Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion

EDITOR PICKS

Konovo Appoints Jessica Santos as Chief Compliance and Privacy Officer

Takeda, Protagonist Secure FDA Priority Review for Rusfertide in Polycythemia Vera

Boston Reclaims Top Spot in U.S. Life Sciences Leasing as Market Stabilizes

THIS WEEK'S STORIES

Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases

KalVista Highlights Patient Satisfaction, Early Treatment Benefits for EKTERLY at Major Allergy Meetings

Enveric Biosciences Says Patent Challenge Has Been Withdrawn

POPULAR CATEGORY

ABOUT US

FOLLOW US